Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04019964
Title Nivolumab in Biochemically Recurrent dMMR Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications

prostate cancer

Therapies

Nivolumab

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST